apposition of the cords can occur normally during quiet sleep in young lambs.3 Briefly, this 'braking' of expiratory airflow by the larynx generates positive subglottic pressure of up to 10 cm water and is an important mechanism in preventing lung collapse in the young until a noncollapsible chest wall is established. If this expiratory laryngeal pressure is prevented, such as by a tracheotomy or endotracheal intubation, respiratory frequency falls and respiratory drive is greatly diminished especially during quiet sleep. Equally, it can be reasoned, if an overdistensible trachea exists or develops, respiratory drive could diminish, and failure or 'unexplained death' occur during respiratory challenge-such as with an apparently trivial infection or upper airways obstruction during sleep. That is to say, positive expiratory pressure could not be developed if the upper airways simply dilated with glottic adduction.
What subglottic pressures are generated in respiratory disease in the young appears to be uncertain. From our studies in early postnatal life we would expect tracheal distension during the expiratory cycle (rather than obstruction) in quiet sleep but such airway collapse could occur in rapid eye movement sleep when upper airway expiratory resistance is slight.
Thus a hypothesis to be tested could be an association between vocal cord necrosis, indicative of chronic laryngeal adduction in expiration, and a distended trachea in these cases. The information from this comprehensive series of necropsies could provide valuable evidence which could point the way to a functional evaluation in such infants possibly averting later morbidity and mortality. We were very well aware of most of the points raised by Paul Johnson but did not wish to speculate too far beyond our evidence. The possibility of spasmodic glottic closure being a major factor in unexpected death is one that we have been studying for many years but unfortunately, as with so many things related to cot death, these vocal cord lesions also occur in children who die in hospital from apparently clinically justifiable disease.' It would be possible, and nice, to do the anatomical correlations that Johnson suggests but the nonspecificity of the vocal cord lesions would be likely to lead to an inconclusive result.
Our own interest has progressed from the general statistical conclusions to the possibility that there is a particular area of tracheomalacia at the carina which enables the trachea to 'block off' at this point and that infection is either absent or present at the laryngeal conus.
It Most coeliac children put on a gluten-free diet will present a normal jejunal mucosa from as soon as a few months up to 1-2 years after introduction of the diet and if they do not one suspects incomplete gluten withdrawal.3 Though some biochemical, haematological, or immunological data can be of help in the follow-up of coeliac children as well as in the assessment of the degree of adherence to the gluten-free diet, a normal jejunal mucosa is the most reliable finding. So, omitting the second biopsy not only fails to confirm the second step to a final diagnosis of gluten-induced enteropathy, but also loses a valuable way of assessing the strictness of dietary treatment.
The criteria of Interlaken,2 including 'the 2-year rule', may be too rigid, but nevertheless they fit with most coeliac children (95 %)4 and in our experience they contribute to an increased accuracy in the diagnosis of coeliac disease.
Until a more complete knowledge is reached concerning permanent, transient (?),5 or latent (?)6 gluten enteropathy or gluten intolerance any escape from the ESPGAN criteria seems undesirable and will confuse rather than help to clarify the diagnosis and management of children with coeliac disease. Dr Dodge comments: I am grateful for Professor Salazar de Sousa's comments. I had intended my paper to be provocative.
In my own practice, I follow the ESPGAN protocol and submit patients to three biopsies. However, this procedure is followed by only two-thirds of the members of ESPGAN1 and I imagine that only a few nonspecialist general paediatricians in this country routinely perform a gluten challenge, followed by a biopsy. Moreover, the challenge procedure varies considerably from putting the patient on a free diet to daily administration of a prescribed large amount of gluten. The postchallenge biopsy is essential if a diagnosis of persistent gluten enteropathy is to be made. I want to encourage paediatricians who are daunted by the present protocol to give a gluten challenge to patients who have benefited clinically and, if known, histologically from a gluten-free diet.
Most of my patients in Cardiff seem to adhere very well to their dietary regimen, and it is exceptional to find one in whom the mucosa has not recovered when a second biopsy is performed. However, simply knowing that the mucosa is still abnormal would not ensure future patient compliance, and I believe that our good results can be attributed to the continuing advice and encouragement given to the parents by our dietician. The primary purpose of my paper was not to challenge the usefulness of the ESPGAN criteria ( 
